RBOT
Vicarious Surgical
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 1
Sell signal 0
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About RBOT
Vicarious Surgical Inc.
A developer of single-incision surgical robot
Life Science Tools and Services
05/06/2020
09/04/2020
New York Stock Exchange
123
12-31
Common stock
78 Fourth Avenue, Waltham, Massachusetts 02451
--
Vicarious Surgical Inc., a company incorporated in Delaware on May 6, 2020. The company is a next-generation robotics company developing disruptive technologies with the goal of improving surgical efficiency, improving patient outcomes and reducing healthcare costs. The company's new surgical approach uses a combination of proprietary humanoid surgical robots and virtual reality to transport surgeons into patients for minimally invasive surgery. The company's technology received a breakthrough device designation from the FDA, and Vicarious Surgical believes that the Vicarious System is the first surgical robot to receive FDA designation. The company is led by a team of experienced technologists, medical device professionals and physicians and is headquartered in Waltham, Massachusetts.
Earnings Call
Q1/2025
Estimate EPS-2.48
Actual EPS-2.58
Estimate Revenue--
Actual Revenue0
Vicarious Surgical's Q1 2025: Unraveling Contradictions on Supply Chains, Clinical Timelines, and Financial Stability
May 20,2025 08:17
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
RBOT has released its 2025 Q1 earnings. EPS was reported at -2.58, versus the expected -2.48, missing expectations. The chart below visualizes how RBOT has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
